TY - JOUR
T1 - Challenges and future for the delivery of growth hormone therapy
AU - Caicedo, Andrés
AU - Rosenfeld, Ron
N1 - Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2018/2
Y1 - 2018/2
N2 - Growth hormone (GH) has multiple roles in sustaining human development and homeostasis. Its pulsatile secretion stimulates growth and contributes to an equilibrium in a process tightly regulated and coordinated by many organs. GH deficiency is a medical condition affecting all ages, with not only significant consequences in the health of the patient but also impact on the quality of life. This review gathers the different strategies used today with a glance at future technologies to treat GH deficiency. We present key aspects for consideration when developing new methods to deliver GH, mimicking or replacing its pulsatile activity. Today and in the future, the fusion of biochemistry, biology and nanotechnology will provide hybrid devices using microfluidic systems. But, until new technologies for GH delivery will become available, current methods must be reinforced in conjunction with the development of better communication strategies between the health system and patients. Treating GH deficiency represents a multidisciplinary effort for which this review provides a glance at potential future directions for this therapy.
AB - Growth hormone (GH) has multiple roles in sustaining human development and homeostasis. Its pulsatile secretion stimulates growth and contributes to an equilibrium in a process tightly regulated and coordinated by many organs. GH deficiency is a medical condition affecting all ages, with not only significant consequences in the health of the patient but also impact on the quality of life. This review gathers the different strategies used today with a glance at future technologies to treat GH deficiency. We present key aspects for consideration when developing new methods to deliver GH, mimicking or replacing its pulsatile activity. Today and in the future, the fusion of biochemistry, biology and nanotechnology will provide hybrid devices using microfluidic systems. But, until new technologies for GH delivery will become available, current methods must be reinforced in conjunction with the development of better communication strategies between the health system and patients. Treating GH deficiency represents a multidisciplinary effort for which this review provides a glance at potential future directions for this therapy.
KW - Growth hormone
KW - Micro Electromechanical Systems (MEMS)
KW - Organs-on-chips
KW - Therapy
KW - eHealth
UR - http://www.scopus.com/inward/record.url?scp=85039047353&partnerID=8YFLogxK
U2 - 10.1016/j.ghir.2017.12.008
DO - 10.1016/j.ghir.2017.12.008
M3 - Artículo
C2 - 29289483
AN - SCOPUS:85039047353
SN - 1096-6374
VL - 38
SP - 39
EP - 43
JO - Growth Hormone and IGF Research
JF - Growth Hormone and IGF Research
ER -